Staidson (300204.SZ) STSA-1002 Injection (Indications for Acute Respiratory Distress Syndrome) Received Summary Report of Phase Ib II Clinical Study.

18:16 08/07/2025

Shutai Shen (300204.SZ) Announcement: The company recently obtained information about STSA-1002 injectable solution (acute respiratory ...

Staidson (300204.SZ) announced that the company recently obtained the summary report of the Ib/II clinical study on STSA-1002 injection (indication for Acute Respiratory Distress Syndrome). The STSA-1002 injection showed preliminary effectiveness and good safety in the Ib/II study, supporting further clinical research.

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.